US 11229599
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
granted A61KA61K31/155A61K31/198
Quick answer
US patent 11229599 (Implant compositions for the unidirectional delivery of therapeutic compounds to the brain) held by The Board of Regents of the University of Texas System expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 62
- CPC classes
- A61K, A61K31/155, A61K31/198, A61K31/282, A61K31/337